[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Sickle Cell Market to Grow by 2023, Predicts Koncept Analytics in Its New Research Report Published at MarketPublishers.com

18 Aug 2017 • by Natalie Aster

LONDON – Known as an inherited genetic blood disorder, sickle cell (SC) disease affects appr. 20-25 million people from pole to pole. Annually, about 300,000 births occur with this disease. The high prevalence of SC disease is observed in such regions as Africa, the Middle East and South Asia. About 10%-40% of the African population carries sickle cell traits.

In the wake of continuous development of drug therapies, the US is predicted to be the 1st region to launch the selling of SC drugs. SC drugs penetration in Europe is also expected to increase in the years to come.

The global SC market is anticipated to gain traction at healthy rates encouraged by such favourable factors as increasing population in the African-American region, ongoing economic improvements, rising expenditures on healthcare, surging SC disorder incidence, amid others. However, the market growth can be seriously restrained by changes in regulatory guidelines, certain associated risks and slow rates of treatment adoption.

At presents, the main trends in the world’s market for SC comprise advancing drug pipeline and escalating research grants.

New research report “Global Sickle Cell Market- Industry Analysis & Outlook (2020-2030)” prepared by Koncept Analytics offers a profound analysis of the current scenario in the global market for sickle cell. Moreover, the report includes granular future forecasts for the market through 2023. The market dynamics is observed in the report with a special focus on the market growth drivers, restraints ad challenges. A detailed regional analysis of the sickle cell market is also available in the report. Additionally, the report is a reliable source of data on the market trends, opportunities and prospects. The report touches upon competitive landscape, covers the leading market participants including Novartis, Bristol-Myers Squibb, Shire Plc, Bluebird Bio and Global Blood Therapeutics.

To find many other research publications prepared by Koncept Analytics follow to the  publisher’s page at MarketPubishers.com.


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]

Analytics & News

Weekly Digest